✦ LIBER ✦

Dermatological adverse effects during genotype-1 hepatitis C treatment with the protease inhibitors telaprevir and boceprevir. Patient management

✍ Scribed by Odile Picard; Patrice Cacoub

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

UK consensus guidelines for the use of t

✍ P. Ramachandran; A. Fraser; K. Agarwal; A. Austin; A. Brown; G. R. Foster; R. Fo 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB

PIN7 The Comparative Efficacy of Telapre

✍ J. Diels; S. Cure; S. Gavart 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Efficacy and safety of telaprevir, a new

✍ N. Hayashi; T. Okanoue; H. Tsubouchi; J. Toyota; K. Chayama; H. Kumada 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

754 IMPACT OF RIBAVIRIN ON SUBGENOMIC HE

✍ W.P. Hofmann; C. Osbahr; T.L. Chung; S. Susser; U. Karey; U. Mihm; C. Welsch; C. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 69 KB

PIN58 Cost Per Sustained Virological Res

✍ A.D. Morais; M.L. Pereira 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PIN62 Cost-Effectiveness of Triple Thera

✍ J.T. Stahmeyer; S. Schauer; D. Wirth; J. Fleischmann; S. Lee; S. Gavart; F. Bian 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB